[A follow-up on the endometrial status of patients in the postmenopause taking hormonal replacement treatment]

Akusherstvo i ginekologiia · 1996 · vol. 35(1-2) , pp. 29–30 · PMID:8967535 · W2416713583
Observational OA: closed CC0
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-10-01 ⓘ

In postmenopausal women receiving hormone replacement therapy, endometrial thickness exceeding 12 mm on ultrasound indicated endometrial hyperplasia in all biopsied cases, supporting dilation and curettage as the appropriate clinical response.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endovaginal ultrasound could be a useful fool for follow-up of patients taking hormone replacement therapy. In the presented study a group of 140 postmenopausal women has been evaluated and in 10 patients the sonography disclosed endometrial thickness of more than 12 mm. Biopsy in the study group revealed three cases of endometrial hyperplasia and all they were in the patients with uterine lining thicker than 12 mm. In patients taking hormone replacement therapy endometrial thickness of more than 12 mm should be regarded as indication for D&C.

My notes (saved in your browser only)

MeSH descriptors

Endometrium Estrogen Replacement Therapy Postmenopause Adult Biopsy Endometrium Endometrium Endometrium Female Follow-Up Studies Humans Middle Aged Postmenopause Ultrasonography

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T22:00:02.201502+00:00
License: CC0 · commercial use OK